Genetics of biliary atresia: Approaches, pathological insights and challenges

Area of Science:

• Pediatric Hepatology
• Neonatal Cholestatic Disorders
• Genetic Liver Diseases

Background:

• Biliary atresia (BA) is a severe neonatal cholestatic disorder characterized by bile duct fibro-obliteration.
• It is a leading cause of pediatric end-stage liver disease and necessitates liver transplantation in children.
• The etiology of BA is heterogeneous, involving genetic and environmental factors like viral infections and immune dysregulation.

Purpose of the Study:

• To review strategies for identifying genetic factors in biliary atresia.
• To highlight the molecular and pathological mechanisms associated with these genetic factors.
• To discuss current challenges in biliary atresia genetic research.

Main Methods:

• Literature review of genetic studies in biliary atresia.
• Analysis of molecular and pathological data related to BA genetics.
• Synthesis of research findings and identification of knowledge gaps.

Main Results:

• Significant heterogeneity exists in the genetic underpinnings of biliary atresia.
• Various genetic factors contribute to defective hepatobiliary development in BA.
• Understanding these genetic factors is crucial for developing targeted therapies.

Conclusions:

• Further research is needed to fully elucidate the complex genetic architecture of biliary atresia.
• Identifying specific genetic variants and pathways will improve diagnostic and therapeutic strategies.
• Overcoming research challenges is essential for advancing the field of pediatric liver disease.